Blar i ODA Open Digital Archive på forfatter "Opheim, Arild"
-
Adapting treatment length to opioid-dependent individuals' needs and preferences: A 2-year follow-up to a 1-year study of extended-release naltrexone
Solli, Kristin Klemmetsby; Opheim, Arild; Latif, Zill-E-Huma; Krajci, Peter; Saltyte Benth, Jurate; Kunoe, Nikolaj; Tanum, Lars Håkon Reiestad (Addiction;, Journal article; Peer reviewed, 2020-12-18)Background and aim: Extended-release naltrexone (XR-NTX) is an underused treatment option for opioid dependence, today only available in a few countries in the world. Although effective, safe and feasible in short-term ... -
Availability of extended-release naltrexone may increase the number of opioid-dependent individuals in treatment: Extension of a randomized clinical trial
Solli, Kristin Klemmetsby; Kunøe, Nikolaj; Latif, Zill-E-Huma; Haase, Kamni Sharma; Opheim, Arild; Krajci, Peter; Gaulen, Zhanna; Saltyte Benth, Jurate; Tanum, Lars Håkon Reiestad (European Addiction Research;2019, Vol. 25, No. 6, Journal article; Peer reviewed, 2019-07-19)Background and objective: Opioid maintenance treatment (OMT) is highly available in Norway, but only 50% of opioid-dependent individuals are enrolled in such programs. This study was aimed at examining if availability of ... -
Risk of Relapse Among Opioid-Dependent Patients Treated With Extended-Release Naltrexone or Buprenorphine-Naloxone: A Randomized Clinical Trial
Opheim, Arild; Gaulen, Zhanna; Solli, Kristin Klemmetsby; Latif, Zill-E-Huma; Fadnes, Lars T.; Saltyte Benth, Jurate; Kunøe, Nikolaj; Tanum, Lars Håkon Reiestad (American Journal on Addictions;Volume 30, Issue 5, September 2021, Peer reviewed; Journal article, 2021-09-06)Background and Objectives: Compare the risk of relapse to heroin and other illicit opioids among opioid‐dependent patients receiving treatment with extended‐release naltrexone (XR‐NTX) or buprenorphine‐naloxone (BP‐NLX). ... -
Risk of relapse to non-opioid addictive substances among opioid dependent patients treated with an opioid receptor antagonist or a partial agonist: A randomized clinical trial
Opheim, Arild; Saltyte Benth, Jurate; Solli, Kristin Klemmetsby; Kloster, Pia Synnøve; Fadnes, Lars T.; Kunøe, Nikolaj; Gaulen, Zhanna; Tanum, Lars Håkon Reiestad (Peer reviewed; Journal article, 2023)ackground and objective: First study to assess any compensatory increase in use of non-opioid illicit substances and alcohol in opioid dependent patients randomized to treatment with extended-release naltrexone (XR-NTX) ...